Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1318.50
15.50
(1.19%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Laboratories launches generic Semaglutide Injection in Canada
>>
Dr. Reddy’s Laboratories informs about press release
>>
Dr. Reddy's Laboratories reports 86% plunge in Q4FY26 consolidated net profit
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab gets Health Canada’s nod for Generic Semaglutide Injection
>>
Dr. Reddy’s Laboratories informs about updates
>>
Dr. Reddy’s Laboratories informs about clarification on news item
>>
Dr. Reddy’s Laboratories informs about compliances certificate
>>
Dr. Reddy's Laboratories to sell entire shareholding in Svaas Wellness
>>
Dr. Reddy’s Laboratories launches Semaglutide injection ‘Obeda’ for Type 2 Diabetes
<<
<
2
3
4
...145
>
>>